IMPORTANCE Macrovascular disease is a leading cause of morbidity and mortality for patients with type 2 diabetes, and medical management, including lifestyle changes, may not be successful at lowering risk.
M acrovascular disease, including coronary artery disease and cerebrovascular disease, is one of the leading causes of morbidity and mortality for patients with type 2 diabetes. As a result, clinical guidelines for the management of type 2 diabetes emphasize lowering macrovascular disease risk factors by optimizing glycemic control, blood pressure, and serum lipid levels. 1, 2 This multifactorial approach has been shown to substantially reduce the incidence of macrovascular complications. 2, 3 However, most patients with type 2 diabetes do not achieve these recommended treatment goals, 4 resulting in continued morbidity and costs. There is evidence from randomized trials that weight loss interventions-including intensive lifestyle modification, pharmacotherapy, and bariatric surgery-can improve macrovascular disease risk factors in patients with type 2 diabetes. To our knowledge, clinical trials have not yet shown that intensive lifestyle intervention and pharmacotherapy for obesity can reduce macrovascular events. [5] [6] [7] [8] [9] In comparison, patients who have bariatric surgery have better glycemic control and greater macrovascular risk factor reduction than those who get both intensive lifestyle and medical treatment combined.
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Several observational studies have provided evidence that bariatric surgery may reduce macrovascular complications of type 2 diabetes when compared with usual medical care, 13 but limitations of these studies include the inability to study contemporary bariatric procedures because of small numbers of patients 14 and unavailability of body mass index measurements for identifying a cohort of nonsurgical matches.
15
To address these concerns, a study was conducted to test the hypothesis that patients undergoing contemporary bariatric procedures would experience a lower rate of macrovascular events than matched patients with severe obesity and type 2 diabetes who received usual care in 4 integrated health insurance and care delivery systems in the United States.
Methods

Settings
A retrospective observational matched cohort study was conducted of adults with type 2 diabetes who underwent bariatric surgery between 2005 and 2011 while enrolled in 1 of 4 US integrated health care systems from the Health Care Systems Research Network: Kaiser Permanente Washington in Washington state, HealthPartners in Minnesota, Kaiser Permanente Northern California, and Kaiser Permanente Southern California. All study procedures were reviewed in advance and approved by the institutional review board at each site and permitted to conduct the research without explicit consent from participants.
Data Sources
At each study site, standardized electronic medical records, insurance claims, and other data systems 16 were used to extract information on enrollment; insurance coverage; demographics; blood pressure; height; weight; laboratory values; medications dispensed; deaths; outpatient, inpatient, and emergency department use; and diagnosis and procedure codes of all enrollees. Race/ethnicity data, which were collected as part of routine clinical care, were extracted from electronic medical records, where they had been entered by clinical staff based on patient self-report using fixed categories.
Surgical Participants
The (HbA 1c ) level greater than or equal to 6.5% (48 mmol/mol) or fasting plasma glucose level greater than or equal to 126 mg/dL (to convert to mmol/L, multiply by 0.0555) at the most recent measurement within 2 years prior to surgery, or (2) medicationtreated type 2 diabetes, defined as a current prescription for any oral or injectable diabetes medication at the time of bariatric surgery. After population selection, the following exclusion criteria were applied based on information in the 2 years before the index date: (1) less than 1 full year of continuous enrollment, (2) a history of cancer (except nonmelanoma skin cancer), (3) pregnancy, (4) gestational diabetes when it was the sole diabetes diagnosis, (5) metformin as the sole indicator of possible type 2 diabetes (ie, no other type 2 diabetes laboratories or diagnoses), (6) pre-existing coronary artery disease or cerebrovascular disease (defined below) or the use of prescription antiplatelet medication, (7) maximum preoperative BMI less than 35, (8) missing preoperative BMI or HbA 1c level in the 2 years before surgery, and (9) unable to match to at least 1 nonsurgical patient ( Figure 1 ).
Matched Nonsurgical Participants
For each patient with bariatric surgery, we identified up to 3 matched nonsurgical controls via a multistep process. First, among all patients with diabetes and BMI greater than or equal to 35 who did not undergo bariatric surgery during the study period (n = 320 345), we identified a pool of potential controls who were enrolled at the time of the surgery, satisfied the study inclusion/exclusion criteria, and matched the patient with bariatric surgery on the basis of study site, sex, age (±10 years), BMI (±5), HbA 1c level (±absolute 1.5%), and insulin use. Second, for each control in the pool, we calculated their Mahalanobis distance (a measure of the distance that accounts for correlation between variables) from the bariatric patient on the basis of age, BMI, HbA 1c level, diabetes duration, and the number of days of health care utilization in the 7 to 24 months prior to the date of surgery. 17 Third, up to 3 controls were selected based on the shortest Mahalanobis distance. Throughout, nonsurgical patients could only be used as a control for 1 surgical patient (matching without replacement). Additional details on the process we used to establish the matched cohort are provided in the eAppendix in the Supplement.
Analyses Outcome and Censoring Definitions
The a priori primary outcome measure was time to incident macrovascular disease (composite indicator of the first occurrence of a coronary artery disease or cerebrovascular event In secondary analyses, each of the coronary artery disease and cerebrovascular outcomes was considered separately. All-cause mortality was also examined as a post hoc exploratory outcome. As in prior studies, 19 death information was drawn from a combination of electronic medical records, administrative databases, and state death indices.
Statistical Models
Cox proportional hazards regression models, fit via the usual partial likelihood, were used to investigate the association between bariatric surgery vs usual care (nonsurgical controls) and incident outcomes. Patients were followed from the index date (the date of bariatric surgery or, for nonsurgical patients, the date of surgery for the patient to whom they had been matched) until the first occurrence of either incident outcome or a censoring event. Based on preliminary analyses, the proportional hazards assumption was assessed to not hold for bariatric surgery vs usual care (P < .001 for an interaction with log-time in the Cox model). We therefore fit a flexible time-varying hazard ratio (HR) association as a function of time since surgery, using restricted cubic splines with knots at the fifth, 35th, 65th, and 95th percentiles of the observed follow-up time scale.
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Cox regression models were used for the primary and secondary outcomes and were adjusted for a priori-identified potential confounders: age, race/ethnicity (Hispanic, nonHispanic white, non-Hispanic black, or non-Hispanic other), surgical year, BMI, smoking status (current, former, or never), duration of observed diabetes before surgery (defined as first observed diagnosis, laboratory value, or prescription indicating type 2 diabetes), insulin use, oral diabetes medication use, uncontrolled blood pressure (defined as either systolic ≥140 or diastolic ≥90 mm Hg at 2 consecutive measures on different days), use of angiotensin converting enzyme inhibitor, angiotensin receptor blocker medications, use of any other antihypertensive medication, insurance type (commercial, Medicare, Medicaid, or other), estimated glomerular filtration rate, low-density lipoprotein (LDL) cholesterol level greater than or equal to 100 mg/dL (to convert to mmol/L, multiply by 0.0259), serum triglyceride level greater than or equal to 150 mg/dL (to convert to mmol/L, multiply by 0.0113), use of cholesterol-lowering medication (statin or other), and history of peripheral arterial disease, hypertension, dyslipidemia, or microvascular disease (diabetic retinopathy, diabetic neuropathy, or diabetes with renal manifestations; end-stage renal disease; or dialysis) before surgery (defined based on ICD-9 and CPT-4 codes). Because of potential variation in care between health care systems, study site (HealthPartners, Kaiser Permanente Southern California, Kaiser Permanente Northern California, and Kaiser Permanente Washington) was adjusted for via stratification of the baseline hazard function. Race/ethnicity was included in the statistical models because it could confound the outcomes by either influencing a patient's ability to receive bariatric surgery or by having a direct effect on the macrovascular outcomes by itself.
Missing data were encountered at baseline for race/ ethnicity, smoking status, blood pressure, estimated glomerular filtration rate, LDL cholesterol, and triglyceride levels. We performed multiple imputation via chained equations, with unordered categorical variables and multinomial logistic regression for imputation of race/ethnicity and smoking status; logistic regression for elevated blood pressure, LDL cholesterol, and triglyceride levels; and linear regression for estimated glomerular filtration rate. 21 Ten imputed data sets were generated, with the results combined using Rubin's rules. Additional detail is provided in the eAppendix in the Supplement.
Sensitivity Analyses
Four sensitivity analyses were conducted to examine the effect of (1) not adjusting for potential confounders that were not included in the matching process (vs adjusting for those confounders in our main analysis), (2) using 1-to-1 and 10-to-1 matching, (3) incorporating all covariates into our Mahalanobis distance calculation (vs our original matching approach), and (4) an additional sensitivity analysis to assess the robustness of the 5-year results to unmeasured confounding using the E-value methodology of VanderWeele and Ding. 22 This estimates what the relative risk would have to be for any unmeasured confounder to overcome the observed association of bariatric surgery with macrovascular disease in this study (see the eAppendix in the Supplement for details).
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The a priori level of statistical significance was set at a 2-sided P value of .05 for all analyses. Because the significance threshold for the secondary analyses was not adjusted for multiple comparisons, these should be interpreted as exploratory. Throughout, we used SAS version 9.4 (SAS Institute) for data manipulation, Stata version 15.1 (StataCorp) for multiple imputation and analysis, and R (R Foundation) for visualization. Table 1 presents descriptive statistics for the final analytic sample of 5301 surgical patients and 14 934 matched nonsurgical patients. Surgical patients were primarily middle-aged, female, had commercial insurance, and more than 40% were racial/ethnic minorities. Seventy-six percent of patients with bariatric surgery underwent Roux-en-Y (RYGB) from 2005 to 2011, 17% underwent sleeve gastrectomy (SG), and 7% underwent adjustable gastric band. Among all patients at the index date, 52% of patients had a BMI of 40 to 49.9, the mean HbA 1c level was 7.2%, and 49% had type 2 diabetes for 5 years or more before baseline. Fewer surgical patients had been current smokers in the 2 years before surgery (9% vs 13%). More nonsurgical patients had a diagnosis of diabetic retinopathy, neuropathy, and renal manifestations, including end-stage renal disease or dialysis. Standardized differences indicate imbalance between surgical and matched nonsurgical patients on a number of variables, including insurance type, days of health care usage, use of other antihypertensive medications, and baseline prevalence of peripheral arterial disease.
Results
Participants
The 1-, 3-, and 5-year retention rates in the analytic sample were similar for nonsurgical (93%, 79%, and 68%, respectively) and surgical (91%, 77%, and 67%, respectively) patients. Median follow-up durations were 4.7 years (interquartile range, 3.3-6.2) for surgical and 4.6 years (interquartile range, 3.1-6.1) for nonsurgical patients. Missing data were encountered for some characteristics at baseline, including race/ ethnicity (12% in the surgical group vs 17% in the nonsurgical group), self-reported smoking status (2% vs 4%, respectively), blood pressure (0% vs 1%, respectively), triglyceride levels (1% vs 4%, respectively), and LDL cholesterol level (67% vs 65%, respectively). Figure 2 and Table 2 provide estimates of the cumulative probability of incident macrovascular disease over time after bariatric surgery and usual nonsurgical care (for matched controls), as well as the cumulative probability of each of the indicators of macrovascular disease (coronary artery disease and cerebrovascular events). The 1-, 3-, 5-, and 7-year rates of incident macrovascular disease were 0.5%, 1.1%, 2.1%, and 3.2%, respectively, after bariatric surgery, and 1.1%, 2.6%, 4.3%, and 6.2% for the matched controls. The cumulative number of macrovascular events at each of these time points is shown in eTable 3 in the Supplement. Rates of incident coronary artery disease and cerebrovascular events were also lower for patients with bariatric surgery than for matched nonsurgical patients (Figure 2B and C; Table 2 ). Table 3 and Figure 3 show the results from the adjusted multivariable Cox models investigating the association between bariatric surgery vs usual care and incident macrovascular disease (see Table 4 for the fully adjusted model with all covariates). Because the effect of surgery was specified in the model as being time-varying using cubic splines, calculating the HRs shown in Table 3 required using all the components of Table 4 and specifying the time points at which the HRs were estimated. Table 3 shows the HRs estimated at 1, 3, 5, and 7 years and Figure 3 shows the HR estimation for all time points. In Table 4 , the most appropriate interpretation of the surgery point estimate in row one is the HR comparing surgery vs no surgery at time zero (the index date). The point estimates for the surgery-by-spline interactions are uninterpretable because of the underlying basis function for the spline. The point estimates for other variables in the model should not be interpreted as unconfounded because this was a matched cohort with respect to surgery and the consideration of confounding was with respect to surgery only, not with respect to these other covariates. As shown in Table 3 , patients who underwent bariatric surgery had a significantly lower risk of incident macrovascular disease at 5 years when compared with matched nonsurgical patients who had not received surgery (2.1% in the surgical group vs 4.3% in the nonsurgical group; HR, 0.60 [95% CI, 0.42-0.86]), as well as a lower 5-year incidence of coronary artery disease (1.6% in the surgical group vs 2.8% in the nonsurgical group; HR, 0.64 [95% CI, 0.42-0.99]). The incidence of cerebrovascular disease was not significantly different between groups at the 5-year time point (0.7% in the surgical group vs 1.7% in the nonsurgical group; HR, 0.69 [95% CI, 0.38-1.25]).
Sensitivity Analyses
Results of the sensitivity analyses are provided in the eFigure in the Supplement. A matched, unadjusted analysis of our primary outcome was not significantly different than the fully adjusted model (eFigure, A in the Supplement). Primary outcome results using 3-to-1 matching were qualitatively similar to using 1-to-1 and 10-to-1 matching (eFigure, B in the Supplement). Primary outcome results were similar to results obtained when all covariates were included in the Mahalanobis distance calculation for matching (eFigure, C in the Supplement). The E-values (relative risk) for the point estimate and upper confidence bound for incident macrovascular disease at 5 years were 2.72 and 1.60, respectively (eAppendix in the Supplement).
Association of Bariatric Surgery vs Usual Care With Mortality (Post Hoc Exploratory Analyses)
The rates of mortality at 1, 3, 5, and 7 years were 0.4%, 0.9%, 1.3%, and 2.0%, respectively, for surgical and 0.9%, 2.7%, 4.5%, Figure 2D ). The cumulative number of deaths at each of these time points is shown in the eAppendix in the Supplement. The risk of allcause mortality was significantly lower at 5 years (HR, 0.33 [95% CI, 0.21-0.52]) among patients who underwent bariatric surgery relative to the matched nonsurgical patients (Table 3 and Figure 3D ).
Discussion
In this retrospective cohort study of patients with type 2 diabetes and severe obesity, bariatric surgery was associated with a lower risk of major macrovascular outcomes compared with usual medical care. These findings have strong biological plausibility and are consistent with other research. Randomized trials have demonstrated that bariatric procedures are more effective than the best-available intensive medical and lifestyle interventions in promoting weight loss, improving glycemic control and serum lipid levels, and reducing the need for medications used to control diabetes, hypertension, and dyslipidemia. 10-12,23-25 Improvements in these parameters after bariatric surgery result in lower cardiovascular risk scores, as measured through validated tools such as the Framingham risk equation. 26, 27 The effect of bariatric surgery also appeared to be dose-dependent, where patients who underwent RYGB procedures (which is associated with greatest initial weight loss) had larger improvements in glycemic control and components of the metabolic syndrome than patients who underwent SG or underwent the adjustable gastric band procedure, 28, 29 although there may also be weight-independent effects of these procedures on glycemic control.
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A few other observational studies have also found an association between bariatric surgery and fewer macrovascular events when compared with usual care. While accumulating data suggest a causal effect of intentional weight loss on lower cardiovascular events and premature mortality, randomized clinical trials to date have not confirmed these findings. The Look AHEAD study randomized 5145 patients with obesity and type 2 diabetes to intensive lifestyle intervention or usual care, but was stopped early because the intervention had no effect on the primary macrovascular disease end point (HR, 0.95 [95% CI, 0.83-1.09]; P = .51). 31 The ongoing Alliance of Randomized Trials of Medicine vs Metabolic Surgery in T2DM (ARMMS-T2D) is an observational follow-up of 4 randomized trials comparing bariatric surgery vs intensive medical and lifestyle treatment, but, with approximately 300 randomized participants, that study may not be powered to assess macrovascular end points. Randomized clinical trials with sufficient power to assess these rare outcomes are unlikely to be conducted because such studies are challenging to conduct and prohibitively expensive.
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Limitations
The study has several limitations. First, the observational design precluded causal inference, and unmeasured confounding may have persisted despite model adjustment for all major cardiovascular risk factors. However, the sensitivity analysis using E-value methodology indicated that the observed 5-year HR of 0.60 for incident macrovascular disease could only be explained by an unmeasured confounder that was associated with both receipt of bariatric surgery and risk of macrovascular disease by a risk ratio of more than 2.72 above and beyond that of the confounders that were measured in this study (upper confidence bound, 1.60). Given that this risk ratio is much greater than any observed for known macrovascular disease risk factors examined in the current study, such as hypertension, diabetes, or hyperlipidemia, it is implausible that an unmeasured confounder exists that can overcome the effect of bariatric surgery observed in the current analysis study (Table 4 ). Second, baseline health characteristics and outcomes were established using data collected during routine medical care and billing, which meant that some information was missing and some comorbid conditions could be misclassified (eg, ICD-9 diagnosis codes could be misapplied); however, major cardiac and cerebrovascular outcomes were more likely to be accurately captured claims for all diagnoses and procedures associated with emergency department and hospital admissions.
Third, cause-specific mortality was not examined because cause of death data were not extracted a priori.
Fourth, loss to follow-up could bias the result if patients who underwent bariatric surgery and left the integrated health care systems in this study had very different macrovascular outcomes than the nonsurgical patients who left these systems.
Fifth, the sample size was insufficient to compare the effectiveness of alternative bariatric procedures for these Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); LDL, low-density lipoprotein; NA, not applicable.
SI conversion factors: To convert LDL cholesterol to mmol/L, multiply by 0.0259; and triglyceride level to mmol/L, multiply by 0.0113.
a The point estimates for the effect of surgery (row 1) on all outcomes are not easily interpretable because they arise from a spline-based model that includes 3 interactions with surgery (surgery by spline [1] , surgery by spline [2] , and surgery by spline [3] ). Because the effect of surgery is specified as being time-varying through a cubic spline, calculating the hazard ratios in Table 3 requires using all components of Table 4 and specifying the time points at which the hazard ratios are to be estimated. In Table 3 , we provide hazard ratios estimated at 1, 3, 5, and 7 years. In Figure 3 , this hazard ratio estimation is presented at all time points. In Table 4 , the most appropriate interpretation of the "surgery" point estimate in row 1 is the hazard ratio comparing surgery vs no surgery at time zero (the index date). The point estimates for the surgery by spline interactions are uninterpretable because of the underlying basis function for the spline. The point estimates for other variables in the model are hazard ratios, although these effects should not be interpreted as unconfounded because this is a matched cohort with respect of surgery and the consideration of confounding is with respect to surgery only, not with respect to these other covariates.
b No cerebrovascular events were observed in the youngest age category.
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outcomes. There has been a shift toward increased use of the SG procedure in recent years in the United States, and although this study included 17% SG, it is unclear whether the benefits observed in a primarily RYGB population will be seen with SG. Sixth, given sample size and statistical constraints related to the number of variables that could be accommodated in the matching process, we could not match on every available characteristic. This left some imbalances in other variables (Table 1 ; standardized differences >10%) that were not part of our matching algorithm. To further address confounding, all variables in Table 1 were adjusted for in our multivariable Cox models.
Conclusions
In this observational study of patients with type 2 diabetes and severe obesity who underwent surgery, compared with those who did not undergo surgery, bariatric surgery was associated with a lower risk of macrovascular outcomes. The findings require confirmation in randomized clinical trials. Health care professionals should engage patients with severe obesity and type 2 diabetes in a shared decision making conversation about the potential role of bariatric surgery in the prevention of macrovascular events. 
eAppendix. Statistical Methods
Overarching strategy
The study design was a matched cohort with surgical cases (i.e. the "exposed") matched to non-cases (i.e. "unexposed"). In identifying matched, unexposed individuals, the most salient point is the need to define the start time, or "time zero" for the time-to-event analyses. For surgical cases, time zero was the date of surgery. Controls had to match by date requiring that they had to be enrolled in the health system on the date of the surgery for the surgical patient they were matched to. Once matched by date, two further matching strategies were considered. One was to construct a model predicting treatment allocation using all patients available for analysis during the study period using propensity scores to identify matched, unexposed individuals. The second strategy was to match directly on a list of a priorispecified covariates that might contribute to confounding bias. This was the approach used for the current study. Propensity score matching was not used because building a single regression model for treatment allocation that acknowledged heterogeneity across patients and across time would be challenging and may not yield an optimal match for important confounding factors. Moreover, the large amount of information available for analysis in this study facilitated matching directly on clinically important covariates, with a key benefit being that it ensures exact balance between the exposed and unexposed patients for many important confounders. A drawback of this matching strategy is that balance is not guaranteed for measured factors not included in the matching algorithm. Adjustment for these factors, however, was achieved by regression modeling.
Construction of analytic datasets
The following steps were used to construct the analytic data set:  Identify all bariatric surgery cases that met the study inclusion/exclusion criteria as specified in the Methods section of the main article. This resulted in a sample of 6,291 surgical patients  Of these, 952 were excluded because of missing pre-operative BMI, HbA1c, and/or serum creatinine measures in the 2 years before surgery, leaving 5,339 patients. See below for additional detail on missing data.  Identify all non-surgical patients with at least one BMI ≥35 kg/m 2 who did not undergo bariatric surgery during the study period (N=320,345).  For each bariatric surgery case:
1. Identify a pool of potential controls who were enrolled at the time of the surgery and satisfied the study inclusion/exclusion criteria.
2. Restrict the pool to patients who matched the bariatric case on the basis of: study site, gender, age (±10 years), BMI (±5 kg/m 2 ), HbA1c level (± absolute 1.5%) and insulin use.
3. For each remaining control calculate the Mahalanobis distance with the bariatric patient on the basis of: age, BMI, HbA1c, diabetes duration, and the number of days of health care utilization in the 7-24 months prior to the date of surgery.
4. Controls were matched to only one case. In instances where a control was eligible for multiple surgery patients, they were assigned to the surgical patient with the lowest number of potential controls; potential control numbers were capped at 20 for these calculations. If two or more surgical patients had the same (lowest) number of controls available, the control in question was randomly assigned to one of the surgical patients.
5. Select up to 3 controls to be retained in the final matched cohort, using the controls with the smallest Mahalanobis distance.  Note, a total of 38 surgical cases were unable to be matched; that is there were no non-surgical patients who matched these patients on the basis of site, age, BMI, insulin use, HbA1c, and gender.
Balance of confounder distributions
Covariate balance was assessed by calculating standardized differences between the baseline characteristics of the surgical and control patients ( Table 1 of the article). Subsequent to this, further adjustment for all potential confounders, including those in the matching process, was achieved by using regression analysis. A detailed justification for including the covariates that were used in the matching process into the Cox regression models is provided by Sjolander and Greenland (Statistics in Medicine, 2013).
Statistical analysis
The primary outcome was a time-to-event phenomenon so Cox regression models were used to examine the association between bariatric surgery and incident macrovascular disease.  Patients were followed from the index date (the date of bariatric surgery or, for non-surgical patients, the date of surgery for the patient for whom they were matched) until the first occurrence of either incident macrovascular disease or a censoring event (e.g., death, disenrollment from the health plans).  Preliminary modeling showed that the proportional hazards assumption did not hold for bariatric surgery vs. usual care (p < 0.001 for an interaction with log-time in the Cox model). Consequently, modeling using a flexible time-varying hazard ratio association was pursued using restricted cubic splines with knots at the 5 th , 35 th , 65 th and 95 th percentiles of the observed follow-up time scale.
 Adjusted models were fit that included: age, race/ethnicity (Hispanic, nonHispanic white, non-Hispanic black, non-Hispanic other), surgical year, BMI, smoking status (current, former, never), duration of observed diabetes before surgery (defined as first observed diagnosis, laboratory value, or prescription indicating T2DM), insulin use, oral diabetes medication use, uncontrolled blood pressure (defined as either systolic ≥ 140 or diastolic ≥ 90 at two consecutive measures on different days), use of ACE-inhibitor, angiotensin receptor blocker (ARB) medications, use of any other antihypertensive medication, insurance type (commercial, Medicare, Medicaid, other), estimated glomerular filtration rate (eGFR), LDL cholesterol ≥2.59 mmol/L (≥100 mg/dL), serum triglycerides ≥1.7 mmol/L (≥150 mg/dL), use of cholesterol lowering medication (statin or other), and history of peripheral arterial disease, hypertension, dyslipidemia, or microvascular disease (diabetic retinopathy, diabetic neuropathy, or diabetes with renal manifestations, end-stage renal disease, or dialysis) before surgery (defined based on ICD-9 and CPT-4 codes).  Because of potential variation in care between health systems, study site (HP, KPSC, KPNC, and KPWA) was adjusted for by stratifying the baseline hazard function. The underlying model that was fit via partial likelihood was one for which the baseline hazard function was specific to the study site. Thus, no assumptions are made regarding between-site differences in risk (such as proportional hazards),, providing the most flexible approach to adjusting for site (at least within the context of a Cox model) Figure 2 in the article plots the cumulative incidence of macrovascular disease among the bariatric cases and controls for all macrovascular, cardiac, and cerebrovascular events and for those who died. These figures are not "unadjusted" as is typical for Kaplan-Meier estimates of incidence since the event rates presented were calculated from the matched cohort (i.e., the surgical patients and non-surgical patients used in the Kaplan-Meier calculations are already matched on site, gender, age, BMI, HbA1c level, insulin use, diabetes duration, and the number of days of health care utilization in the 7-24 months prior to the date of surgery). Because our sensitivity analysis comparing the matched adjusted Cox models and matched unadjusted Cox models (see Appendix Figure 4 -A) yield nearly identical results, the cumulative incidence plots are a reasonable approximation of the underlying rates in the two groups.
Cumulative incidence plots
Standard error estimation
Since all covariates used in the construction of the matched cohort were included in the model, no further statistical adjustment for the design was necessary to obtain valid standard error estimates.
Missing data
Missing data occurred at two points in the study. Of the 6,291 bariatric cases, 952 (15%) who met the inclusion/exclusion criteria had missing pre-operative BMI, HbA1c, and/or serum creatinine measures in the 2 years before surgery. The second source for missing data was within the final matched cohort where patients might have had some baseline covariates missing. Most commonly these were race/ethnicity and/or smoking status and/or elevated blood pressure and/or elevated triglyceride levels and/or elevated LDL levels.
Appendix Table 5 compares the baseline characteristics of the 15% of surgical patients who did not have either a pre-operative BMI or HbA1c and were lost during the matching process compared with patients who had complete pre-operative data. Surgical patients with missing data were similar for most characteristics. The characteristics that did differ (such as year of their surgical procedure and duration of observed diabetes) suggest that patients with missing data were either new to our health care systems (i.e., had not been receiving care long enough to have all of these baseline data captured) or had undergone their bariatric procedure outside of our integrated network. For example, these patients were more often from one of our health systems (HealthPartners: 35% of missing vs. 5% non-missing); more often non-
